Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study
Michelle T. Long, Xiaoyu Zhang, Hanfei Xu, et al.
Hepatology (2020) Vol. 73, Iss. 2, pp. 548-559
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive Mendelian randomization study
Jiarong Xie, Hangkai Huang, Zhening Liu, et al.
Hepatology (2022) Vol. 77, Iss. 3, pp. 949-964
Open Access | Times Cited: 158
The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk
Cyrielle Caussy, Adrien Aubin, Rohit Loomba
Current Diabetes Reports (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 152
Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease
Fredrik Åberg, Christopher D. Byrne, Carlos J. Pirola, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 1, pp. 191-206
Open Access | Times Cited: 149
Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases
Jorge Gutiérrez‐Cuevas, Arturo Santos, Juan Armendáriz‐Borunda
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11629-11629
Open Access | Times Cited: 145
Association between SII and hepatic steatosis and liver fibrosis: A population-based study
Ruijie Xie, Mengde Xiao, Lihong Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 144
Natural history and progression of metabolic dysfunction-associated steatotic liver disease
Hannes Hagström, Ying Shang, Hannes Hegmar, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 10, pp. 944-956
Closed Access | Times Cited: 33
Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025
Elke Roeb, Ali Canbay, Frank Tacke, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 09, pp. 1346-1421
Open Access | Times Cited: 53
Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) study
Neeta B. Amin, Amanda Darekar, Quentin M. Anstee, et al.
BMJ Open (2022) Vol. 12, Iss. 3, pp. e056159-e056159
Open Access | Times Cited: 39
Racial and ethnic differences and the role of unfavorable social determinants of health across steatotic liver disease subtypes in the United States
Pedro Ochoa‐Allemant, Jorge A. Marrero, Marina Serper
Hepatology Communications (2023) Vol. 7, Iss. 12
Open Access | Times Cited: 28
Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality
Stefano Ballestri, Alessandro Mantovani, Maria Di Girolamo, et al.
Metabolism and Target Organ Damage (2023) Vol. 3, Iss. 1, pp. 1-1
Open Access | Times Cited: 27
Screening for liver fibrosis: lessons from colorectal and lung cancer screening
Maja Thiele, Patrick S. Kamath, Isabel Graupera, et al.
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 7, pp. 517-527
Closed Access | Times Cited: 10
Liver Fibrosis Associated with More Severe Motor Deficits in Early Parkinson’s Disease
Aryeh Zolin, Hwai Ooi, Manqi Zhou, et al.
Clinical Neurology and Neurosurgery (2025), pp. 108861-108861
Closed Access | Times Cited: 1
Screening for Liver Fibrosis in the General Population: Where Do We Stand in 2022?
Clémence M. Canivet, Jérôme Boursier
Diagnostics (2022) Vol. 13, Iss. 1, pp. 91-91
Open Access | Times Cited: 25
New Insights into Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: The Liver-Heart Axis
Georgiana-Diana Cazac, C.M. Lǎcǎtusu, Cătălina Mihai, et al.
Life (2022) Vol. 12, Iss. 8, pp. 1189-1189
Open Access | Times Cited: 23
Impact of non-alcoholic fatty liver disease and liver fibrosis on outcomes of acute ischemic stroke: A systematic review and meta-analysis
Liting Yang, Jian Han, Chenghui Qin, et al.
Pakistan Journal of Medical Sciences (2025) Vol. 41, Iss. 2, pp. 630-636
Open Access
Association Between Liver Fibrosis and Risk of Incident Stroke and Mortality: A Large Prospective Cohort Study
Zijie Wang, Zhitao Gong, Jianshang Wen, et al.
Journal of the American Heart Association (2025)
Open Access
Alcohol Intake and Cardiometabolic Risk Factors Are Independently Associated With a Higher AST/Platelet Ratio Index in Obese Males
Hideki Fujii, Yoshihiro Kamada, Yuichiro Suzuki, et al.
Liver international communications. (2025) Vol. 6, Iss. 1
Open Access
Association of Alpha-1 Acid Glycoprotein with Hepatic Steatosis and Liver Fibrosis Among Women: A Population-Based Study
S.L. Wang
Research Square (Research Square) (2025)
Closed Access
Association of MPO levels with cardiometabolic disease stratified by atherosclerotic cardiovascular risk and intensity of therapy in a workforce population
Olga A. Iakoubova, Farnoosh Haji‐Sheikhi, Judy Z. Louie, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Fatty Liver Disease: Diagnosis and Stratification
Yedidya Saiman, Andrés Duarte‐Rojo, Mary E. Rinella
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 529-544
Open Access | Times Cited: 32
Association between liver fibrosis and incident dementia in the UK Biobank study
Neal S. Parikh, Hooman Kamel, Cenai Zhang, et al.
European Journal of Neurology (2022) Vol. 29, Iss. 9, pp. 2622-2630
Open Access | Times Cited: 21
Nonheavy Alcohol Use Associates With Liver Fibrosis and Nonalcoholic Steatohepatitis in the Framingham Heart Study
Brooke A. Rice, Timothy S. Naimi, Michelle T. Long
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 11, pp. 2854-2863.e2
Open Access | Times Cited: 19
Metabolic dysfunction-associated steatotic liver disease-related hepatic fibrosis increases risk of insulin resistance, type 2 diabetes, and chronic kidney disease
Weijing Zhang, Wen Jing Song, Weiyu Chen, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 6, pp. 802-810
Open Access | Times Cited: 4
Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease
Amedeo Lonardo, Stefano Ballestri, György Baffy, et al.
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 4
Consensus Guidelines for the Diagnosis and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Adult Asian Indians with Type 2 Diabetes
Anoop Misra, Ashish Kumar, Mohammad Shafi Kuchay, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2025) Vol. 19, Iss. 3, pp. 103209-103209
Closed Access
Page 1 - Next Page

Scroll to top